Galectin Therapeutics Inc. · NASDAQ:GALT
Jamil Khurram sold 52,037 Galectin Therapeutics Inc. shares (Form 4)
Traded Jun 26 to Jun 29, 2026 · Filed Jun 30, 2026
From Jun 26 to Jun 29, 2026, Jamil Khurram (Chief Medical Officer) sold 52,037 Galectin Therapeutics Inc. shares at an average US$5.04 for US$262K under a trading plan, leaving 0 shares. Filed Jun 30, 2026 (Form 4).
- Sold
- 52,037 shares
- Price
- US$5.04 average (US$5.00 to US$5.04)
- Value
- US$262K
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 26, 2026 | Common Stock | Option exercise | 2,037 | US$2.20 | 2,037 | Direct |
| Jun 26, 2026 | Common Stock | Sale | 2,037 | US$5.00 | 0 | Direct |
| Jun 26, 2026 | Common Stock | Option exercise | 2,533 | US$2.50 | 2,533 | Direct |
| Jun 26, 2026 | Common Stock | Sale | 2,533 | US$5.00 | 0 | Direct |
| Jun 29, 2026 | Common Stock | Option exercise | 47,467 | US$2.50 | 47,467 | Direct |
| Jun 29, 2026 | Common Stock | Sale | 47,467 | US$5.04 | 0 | Direct |
Source
Related
- Galectin Therapeutics Inc.
- Jamil Khurram
- Galectin Therapeutics Inc. shareholders
- Form 4 · Jamil Khurram · Jul 16, 2026
- Form 4 · Jamil Khurram · Jun 25, 2026
- Form 4 · Jamil Khurram · May 28, 2026
- Form 4 · Richard E. Uihlein · Aug 4, 2026
- Schedule 13D/A · Richard E. Uihlein · Aug 4, 2026
- Form 4 · Shlevin Harold H. · Jun 30, 2026